Clinical trials
Phase 1 Gaucher Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 4 |
| Genzyme, a Sanofi Company | 2 |
| ISU Abxis Co., Ltd. | 2 |
| Protalix | 2 |
| Amicus Therapeutics | 1 |
| National Center for Research Resources (NCRR) | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| New York Medical College | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gaucher Disease | 22 |
| Metabolism, Inborn Errors | 3 |
| Mucopolysaccharidosis VI | 2 |
| Wolman Disease | 2 |
| Adrenoleukodystrophy | 1 |
| Anemia, Aplastic | 1 |
| Anemia, Diamond-Blackfan | 1 |
| Fucosidosis | 1 |
| Genetic Diseases, Inborn | 1 |
| Leukemia, Myeloid, Acute | 1 |
Trials
Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.